Abdelmawla, N, Ahmed, MI (2009) Clozapine and risk of pneumonia. British Journal of Psychiatry 194: 468–469.
Google Scholar | Crossref | Medline Cicala, G, Barbieri, MA, Spina, E, et al. (2019) A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. Expert Review of Clinical Pharmacology 12: 219–234.
Google Scholar | Crossref | Medline De Leon, J, Sanz, EJ, De Las Cuevas, C (2020) Data from the World Health Organization’s Pharmacovigilance Database supports the prominent role of pneumonia in mortality associated with clozapine adverse drug reactions. Schizophrenia Bulletin 46: 1–3.
Google Scholar | Crossref | Medline Department for Communities and Local Government (2010) Indices of deprivation 2010. Available at: http://data.london.gov.uk/dataset/indices-deprivation-2010
Google Scholar Fried, AJ, Bonilla, FA (2009) Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clinical Microbiology Reviews 22: 396–414.
Google Scholar | Crossref | Medline Govind, R, Fonseca, DE, Freitas, D, et al. (2020) Clozapine treatment and risk of COVID-19 infection: Retrospective cohort study. British Journal of Psychiatry 219(1): 1–7.
Google Scholar Hinkes, R, Quesada, TV, Currier, MB, et al. (1996) Aspiration pneumonia possibly secondary to clozapine-induced sialorrhea. Journal of Clinical Psychopharmacology 16: 462–463.
Google Scholar | Crossref | Medline | ISI Jolles, S, Borrell, R, Zouwail, S, et al. (2014) Calculated globulin (CG) as a screening test for antibody deficiency. Clinical and Experimental Immunology 177: 671–678.
Google Scholar | Crossref | Medline | ISI Kuo, CJ, Yang, SY, Liao, YT, et al. (2013) Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. Schizophrenia Bulletin 39: 648–657.
Google Scholar | Crossref | Medline | ISI Landry, P, Benaliouad, F, Tessier, S (2003) Increased use of antibiotics in clozapine-treated patients. International Clinical Psychopharmacology 18: 297–298.
Google Scholar | Medline Li, XH, Zhong, XM, Lu, L, et al. (2020) The prevalence of agranulocytosis and related death in clozapine-treated patients: A comprehensive meta-analysis of observational studies. Psychological Medicine 50: 583–594.
Google Scholar | Crossref | Medline Lozano, R, Marin, R, Santacruz, MJ, et al. (2016) Effect of clozapine on immunoglobulin M plasma levels. Therapeutic Advances in Psychopharmacology 6: 58–60.
Google Scholar | SAGE Journals | ISI Nielsen, J, Foldager, L, Meyer, JM (2009) Increased use of antibiotics in patients treated with clozapine. European Neuropsychopharmacology 19: 483–486.
Google Scholar | Crossref | Medline | ISI Ponsford, M, Castle, D, Tahir, T, et al. (2018) Clozapine is associated with secondary antibody deficiency. British Journal of Psychiatry 214: 1–7.
Google Scholar Ponsford, MJ, Jolles, S (2019) Antibody deficiency in patients taking clozapine. BMJ 364: l483.
Google Scholar | Crossref | Medline Ponsford, MJ, Steven, R, Bramhall, K, et al. (2020) Clinical and laboratory characteristics of clozapine-treated patients with schizophrenia referred to a national immunodeficiency clinic reveals a B-cell signature resembling common variable immunodeficiency (CVID). Journal of Clinical Pathology 73: 587–592.
Google Scholar | Crossref | Medline Roge, R, Moller, BK, Andersen, CR, et al. (2012) Immunomodulatory effects of clozapine and their clinical implications: What have we learned so far? Schizophrenia Research 140: 204–213.
Google Scholar | Crossref | Medline | ISI Stoecker, ZR, George, WT, O’Brien, JB, et al. (2017) Clozapine usage increases the incidence of pneumonia compared with risperidone and the general population: A retrospective comparison of clozapine, risperidone, and the general population in a single hospital over 25 months. International Clinical Psychopharmacology 32: 155–160.
Google Scholar | Crossref | Medline Taylor, DM, Douglas-Hall, P, Olofinjana, B, et al. (2009) Reasons for discontinuing clozapine: Matched, case-control comparison with risperidone long-acting injection. British Journal of Psychiatry 194: 165–167.
Google Scholar | Crossref | Medline | ISI Villasante-Tezanos, AG, Rohde, C, Nielsen, J, et al. (2020) Pneumonia risk: Approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia. Acta Psychiatrica Scandinavica 142: 66–67.
Google Scholar | Crossref | Medline